Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial is conducted in Europe. Growth Hormone in young adults with growth hormone deficiency in childhood. This trial compares a treated group of patients with an untreated group of patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| somatropin | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in bone mineralisation | After 2 years treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Other markers of bone mineral content. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novo Nordisk Investigational Site | Parkville | Victoria | 3052 | Australia | ||
| Novo Nordisk Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Result | Zacharin M, Szarras-Czapnik M, Racz K, Keller A, Tauber M, Conway G. Growth hormone (GH) treatment improves bone mineral density during transition of GH-deficient patients from adolescence to adulthood. European Society for Paediatric Endocrinology (ESPE) 2007; Country: Finland City: Helsinki | ||
| Result | Zacharin M, Keller A, Chanson P, Conway G on behalf of the 1369 GHD to GHDA. Efficacy of two years' growth hormone (GH) treatment on bone mineral density in young adults with childhood-onset GH deficiency. The Endocrine Society Annual Meeting (ENDO) 2007; Country: Canada City: Toronto | ||
| Result | Conway G, Scarras-Czapnik M, Racz K, Keller A, Chanson P, Kappelgaard A M, Zacharin M, Hyldstrup L. Direct X-ray radiogrammetry versus dual-energy X-ray absorptiometry: assessment of bone density in young adult with childhood-onset growth hormone deficiency treated with growth hormone. The Endocrine Society Annual Meeting (ENDO) 2008; Country: USA City: San Francisco |
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Auckland |
| 1 |
| Australia |
| Novo Nordisk Investigational Site | Hamilton | 2303 | Australia |
| Novo Nordisk Investigational Site | Subiaco | 6008 | Australia |
| Novo Nordisk Investigational Site | Graz | 8036 | Austria |
| Novo Nordisk Investigational Site | Brussels | 1200 | Belgium |
| Novo Nordisk Investigational Site | Le Kremlin-Bicêtre | 94275 | France |
| Novo Nordisk Investigational Site | Marseille Cédex 05 | 13385 | France |
| Novo Nordisk Investigational Site | Toulouse | 31059 | France |
| Novo Nordisk Investigational Site | Essen | 45122 | Germany |
| Novo Nordisk Investigational Site | Frankfurt | 60590 | Germany |
| Novo Nordisk Investigational Site | Heidelberg | 69115 | Germany |
| Novo Nordisk Investigational Site | Krefeld | 47805 | Germany |
| Novo Nordisk Investigational Site | Leipzig | 04317 | Germany |
| Novo Nordisk Investigational Site | Magdeburg | 39112 | Germany |
| Novo Nordisk Investigational Site | Budapest | 1088 | Hungary |
| Novo Nordisk Investigational Site | Budapest | 1135 | Hungary |
| Novo Nordisk Investigational Site | Szeged | 6720 | Hungary |
| Novo Nordisk Investigational Site | Oslo | 0027 | Norway |
| Novo Nordisk Investigational Site | Cracow | 30-663 | Poland |
| Novo Nordisk Investigational Site | Gdansk | 80-952 | Poland |
| Novo Nordisk Investigational Site | Szczecin | 71-455 | Poland |
| Novo Nordisk Investigational Site | Warsaw | 04-736 | Poland |
| Novo Nordisk Investigational Site | Wroclaw | 50-376 | Poland |
| Novo Nordisk Investigational Site | Barcelona | 08035 | Spain |
| Novo Nordisk Investigational Site | Gothenburg | 413 45 | Sweden |
| Novo Nordisk Investigational Site | Bern | 3010 | Switzerland |
| Novo Nordisk Investigational Site | Lausanne | 1011 | Switzerland |
| Novo Nordisk Investigational Site | Glasgow | G11 6NT | United Kingdom |
| Novo Nordisk Investigational Site | London | W1N 8AA | United Kingdom |
| ID | Term |
|---|---|
| D004393 | Dwarfism, Pituitary |
| ID | Term |
|---|---|
| D004392 | Dwarfism |
| D001848 | Bone Diseases, Developmental |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D001849 | Bone Diseases, Endocrine |
| D007018 | Hypopituitarism |
| D010900 | Pituitary Diseases |
| D007027 | Hypothalamic Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019382 | Human Growth Hormone |
| ID | Term |
|---|---|
| D013006 | Growth Hormone |
| D010908 | Pituitary Hormones, Anterior |
| D010907 | Pituitary Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided